EARLY Labs

EARLY Labs is at the forefront of medical and diagnostic innovation, pioneering a breakthrough multi-cancer screening test. Dedicated to early detection, EARLY Labs provides a novel Volatile Markers (VM) test, designed to identify cancer at its most curable stages. This innovative approach is tailored to meet the requirements of large-scale population screening programs, ensuring the test is acceptable, affordable, and accessible to all.

Leveraging a simple, safe, and highly sensitive urine test, EARLY Labs' proprietary platform enables diagnostic-level testing on a population-wide scale. Starting with lung cancer, EARLY Labs is set to revolutionize cancer detection, significantly reducing the global human and financial burden of the disease. The company is headquartered in Netanya, IL, and is committed to expanding its technology to detect various cancer types, creating a comprehensive multi-cancer screening platform.

EARLY Labs is dedicated to advancing healthcare through innovative diagnostic solutions. The company’s management is completing further information to showcase the full scope of its capabilities. We invite the manager of EARLY Labs to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.